Clinical Trials Logo
  1. Home
  2. Peritonitis
  3. NCT03284476
  4. Details
NCT03284476 Clinical Trial

Post Surgically Treated Peritonitis Complications

Peritonitis Clinical Trial

Official title:
A Prospective Cohort of Patients Hospitalized in West French Intensive Care Units for Peritonitis Surgically Treated

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT03284476
Other study ID # RC12_0207 doublon
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date April 2013
Est. completion date June 2020

Study information
Verified date June 2020
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this observational study is to investigate the management and the complications associated wtih surgically treated peritonitis.

Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.

Description:

Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria:

- Nosocomial surgically treated Peritonitis

- Or Community-Acquired surgically treated Peritonitis

- Or Post-operative surgically treated Peritonitis

Exclusion Criteria:

- Consent withdrawal

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Collection of medical data from ICU patients
Medical data collected on a electronic secured data base

Locations
Country Name City State
France Angers University Hospital Angers
France Nantes University Hospital Nantes
France Poitiers University Hospital Poitiers
France Rennes University Hospital Rennes
France Tours University Hospital Tours

Sponsors (1)
Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Other Death In ICU (up to 90 days)
Primary In ICU stay main complications Nosocomial Infections (epidemiology, risk factors, antibiotic susceptibility of pathogens) Organ failures (incidence, risk factors) Within the first 28 days after ICU admission date
Secondary Duration of mechanical ventilation In ICU (up to 90 days)
Secondary ICU length of stay In ICU (up to 90 days)
See also
  Status Clinical Trial Phase
Completed NCT04070196 - Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients N/A
Completed NCT00657566 - SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection Phase 3
Recruiting NCT00131196 - Functional Genomic Influences on Disease Progression and Outcome in Sepsis N/A
Completed NCT00195351 - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Phase 4
Completed NCT04182217 - Descriptive and Correlational Study of Peritonitis in Haiti.
Recruiting NCT03310606 - Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis N/A
Completed NCT01222663 - Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock Phase 3
Completed NCT00230971 - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Phase 4
Recruiting NCT03790176 - ZAVI APD ELF Protocol v2.2 Phase 1
Completed NCT03668197 - Children Peritonitis Ecology at CHU de Rennes - (IIAPEDIA)
Recruiting NCT01837342 - Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery N/A
Completed NCT00497744 - A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis N/A
Recruiting NCT03334006 - Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial). Phase 2
Terminated NCT03403751 - Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Phase 3
Withdrawn NCT00463762 - Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Phase 4
Active, not recruiting NCT02755610 - Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis N/A
Not yet recruiting NCT05308849 - Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis N/A
Completed NCT02726932 - Intra-abdominal View and Inflammatory Markers in Secondary Peritonitis - Correlation to Recovery
Recruiting NCT05050253 - Lavage With Super-Oxidized Solution for Secondary Peritonitis N/A
Completed NCT02926846 - IV Antibiotics With Lavage for Severe PD Peritonitis Phase 4